NCT06257472

Efficacy of Virtual Reality (VR) for Irritable Bowel Syndrome

Name: Clinical Trial NCT06257472
Creator: Anthony Lembo
Keywords: IBS - Irritable Bowel Syndrome, Virtual Reality Headset, device, clinical trial, United States of America

Efficacy of Virtual Reality (VR) for Irritable Bowel Syndrome: A Randomized Trial Comparing Brain-Gut Directed VR vs. Sham VR

Anthony Lembo·ClinicalTrials.gov·device·Device trialRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: IBS - Irritable Bowel Syndrome
Drug/Device/Intervention: Virtual Reality Headset
Study type: Interventional
Intervention type: device

Sponsor & location

Primary sponsor: Anthony Lembo
Funder: The Cleveland Clinic
Location: Los Angeles,Cleveland, United States of America

Timeline & enrollment

Phase: N/A
Start date: Jun 01, 2024
End date: Feb 01, 2025
Enrollment: 75 participants

Primary outcome

IBS-targeted HRQOL (health-related quality of life)

Summary

In this study, the investigators conduct a remote, eight-week, two-arm, randomized controlled trial that assesses the benefits, primarily measured through the irritable bowel syndrome (IBS)-targeted HRQOL (health-related quality of life), of an immersive, disease-targeted virtual reality program compared to a non-immersive virtual reality program for patients with IBS.

ICD-10 classifications

Irritable bowel syndrome with predominant constipation [IBS-C]Irritable bowel syndromeIrritable bowel syndrome with predominant diarrhoea [IBS-D]Irritable bowel syndrome with mixed bowel habits [IBS-M]Other and unspecified irritable bowel syndrome

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06257472
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT06257472 through Pure Global AI's free database. This phase not specified trial is sponsored by Anthony Lembo and is currently Recruiting. The study focuses on IBS - Irritable Bowel Syndrome. Target enrollment is 75 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.